A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know [Yahoo! Finance]
ImmunityBio, Inc. (IBRX)
Company Research
Source: Yahoo! Finance
This new position ranks as the fund's 2nd-largest holding, representing 4.4% of AUM These 10 stocks could mint the next wave of millionaires › Heights Capital Management recently established a new position in ImmunityBio (NASDAQ:IBRX) , buying 6,565,709 shares valued at approximately $16.15 million. What happened Heights Capital Management disclosed a new purchase of 6,565,709 ImmunityBio shares in its quarterly report filed with the U.S. Securities and Exchange Commission on November 14, 2025. The stake, valued at approximately $16.15 million at quarter-end, was not present in the previous filing and now accounts for 4.4% of the firm's reportable assets under management. What else to know This is a new position for Heights Capital Management, representing 4.4% of its $364.74 million reportable U.S. equity assets as of September 30, 2025. Top holdings after the filing: FLUT: $74.7 million (20.5% of AUM) IBRX: $16.15 million (4.4% of AUM) NNE: $14.1 million (3.9% o
Show less
Read more
Impact Snapshot
Event Time:
IBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IBRX alerts
High impacting ImmunityBio, Inc. news events
Weekly update
A roundup of the hottest topics
IBRX
News
- ImmunityBio, Inc. (IBRX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- ImmunityBio (IBRX) Slashes 9% on Lack of Leads [Yahoo! Finance]Yahoo! Finance
- A Second Anktiva Approval Could Be The Catalyst ImmunityBio Needs [Seeking Alpha]Seeking Alpha
- A Fresh Look at ImmunityBio (IBRX) Valuation After Recent Share Rally [Yahoo! Finance]Yahoo! Finance
- ImmunityBio (IBRX) Soars 10.8% Ahead of Health Conferences [Yahoo! Finance]Yahoo! Finance
IBRX
Earnings
- 5/12/25 - Miss
IBRX
Analyst Actions
- 9/10/25 - HC Wainwright
IBRX
Sec Filings
- 11/10/25 - Form SCHEDULE
- 11/5/25 - Form 8-K
- 11/5/25 - Form 10-Q
- IBRX's page on the SEC website